Study: Very Low Doses Of THC Can Help Treat Pain

Israeli researchers have conducted clinical trials seeking to demonstrate that pain can be effectively relieved using targeted micro-doses of THC.

The study suggests that using a Selective-Dose Inhaler three to four times per day can relieve pain with a dose of just 500 micrograms of THC, one of the main chemical compounds found in cannabis.

Tel Aviv-based Syqe Medical produces the Selective-Dose Inhaler.

The study concluded that using the inhaler delivers significantly low and precise doses of THC, allowing the administration of inhaled cannabis-based medicines according to high pharmaceutical standards.

This can produce safe and effective analgesia in patients with chronic pain, researchers reported.

The placebo-controlled, double-blind, multi-dose study was conducted at Rambam Hospital in Haifa and led by Prof. Elon Eisenberg, Dean of the Faculty of Medicine at the Technion-Israel Institute of Technology. The findings were published in the European Journal of Pain.

“We were very surprised to see that a modest 500 microgram increment in the dose almost doubled the psychoactive effect," said Syqe CEO Perry Davidson.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsHealth CareSmall BusinessMarketsGeneralcannabis industrycannabis sales
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.